In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
Johnson & Johnson MedTech has received FDA approval for its device for drug-refractory paroxysmal atrial fibrillation.
Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...
or AFib, in people who had electronic devices implanted in their chests to help monitor and regulate their heartbeats, the ...
PRNewswire New York [US] 13 Fourth Frontier a medical technology company based out of New York and Bangalore announced the ...
Professor Allan Lawrie discusses the future of personalised cardiovascular disease detection and monitoring and wearable ...
Wearable AF monitoring devices are extensively used ... and maintaining normal sinus rhythm. Atrial Fibrillation (AF) is the most common sustained heart arrhythmia in adults, affecting ...
Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback